Minerva obstetrics and gynecologyHumansPolycystic Ovary SyndromeFemaleInsulin ResistanceAndrogen Antagonists
Antiandrogens and insulin sensitizers in PCOS management.
Stefano Lello, Anna Fagotti, Laura Colonna, Giovanni DI Lella, Michele Vignali, Anna Capozzi
Published: 202510.23736/S2724-606X.25.05822-1
Abstract
BACKGROUND: Polycystic ovary syndrome (PCOS) is an endocrine/metabolic condition. Hyperandrogenism and insulin-resistance with compensatory hyperinsulinemia are important features of PCOS. The aim of this paper is to review the rationale of antiandro…
Preview only. Read the full abstract at the source